SC Filed 2019-11-21 Event — SEC 0001193125-19-297616 →

Bain Capital Life Sciences Fund, L.P. → Dicerna Pharmaceuticals Inc

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

14 filings by this filer

13 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Dicerna Pharmaceuticals Inc

Filed	Form	Filer	Stake	Shares
2020-12-14	SC	Bain Capital Life Sciences Fund, L.P.	—	—	view →
2019-12-06	SC	Bain Capital Life Sciences Fund, L.P.	—	—	view →
2019-05-31	SC	Bain Capital Life Sciences Fund, L.P.	—	—	view →
2018-03-27	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →
2018-01-19	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →

Other Filings by Bain Capital Life Sciences Fund, L.P.

Filed	Form	Issuer	Stake	Shares
2022-08-17	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2021-08-27	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2021-08-11	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2021-06-11	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2021-03-26	SC	Aptinyx Inc.	—	—	view →
2021-02-08	SC	Arcutis Biotherapeutics, Inc. ARQT	—	—	view →
2020-12-14	SC	Dicerna Pharmaceuticals Inc	—	—	view →
2020-10-27	SC	Aptinyx Inc.	—	—	view →
2020-05-28	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2020-03-12	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2020-01-16	SC	Aptinyx Inc.	—	—	view →
2019-12-06	SC	Dicerna Pharmaceuticals Inc	—	—	view →
2019-05-31	SC	Dicerna Pharmaceuticals Inc	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →